VRDN 008
Alternative Names: VRDN-008Latest Information Update: 24 Nov 2023
At a glance
- Originator Viridian Therapeutics
- Class Antibodies
- Mechanism of Action Neonatal Fc receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Autoimmune disorders